Get the Stockscreener App
0.46
1.66%
0.0075
Cardio Diagnostics Holdings Inc stock is traded at $0.46, with a volume of 911.47K.
It is up +1.66% in the last 24 hours and down -4.17% over the past month.
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
See More
Previous Close:
$0.4525
Open:
$0.4505
24h Volume:
911.47K
Relative Volume:
0.16
Market Cap:
$23.60M
Revenue:
-
Net Income/Loss:
$-9.37M
P/E Ratio:
-0.5056
EPS:
-0.9099
Net Cash Flow:
$-7.34M
1W Performance:
-8.82%
1M Performance:
-4.17%
6M Performance:
+21.82%
1Y Performance:
-70.89%
1-Day Range:
$0.4255
$0.4782
1-Week Range:
$0.4255
$0.5335
52-Week Range:
$0.19
$1.82
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
0.4567 | 23.60M | 0 | -9.37M | -7.34M | -0.9099 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.82 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.52 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
616.37 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.67 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
268.23 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Cardio Diagnostics Unveils Strategic Vision for Future Growth - TipRanks
This morning’s top pick is Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) - US Post News
Potential Price Increase for Cardio Diagnostics Holdings Inc (CDIO) After Recent Insider Activity - Knox Daily
Cardio Diagnostics Holdings Inc (CDIO) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Cardio Diagnostics Holdings Inc (CDIO) Stock: A Closer Look at the Market Potential - The News Heater
A Look at Cardio Diagnostics Holdings Inc (CDIO) Shares in the Recent Past Indicates Growth - SETE News
Unlocking AI: Is Cardio Diagnostics Holdings the Next Big Thing? - Jomfruland.net
Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships - Insider Monkey
Cardio Diagnostics Holdings Inc (CDIO) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Cardio Diagnostics Holdings Inc (CDIO) presents a great opportunity, but the stock is slightly undervalued - US Post News
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations - Business Wire
AI-Powered Heart Disease Testing Breakthrough: Cardio Diagnostics Signs 7 Strategic Healthcare Alliances - StockTitan
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - br.ADVFN.com
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) Is A Buzzing Hot Stock - Stocks Register
Heart Attack Diagnostics Market Booms with AI, Biomarkers, and Cutting-Edge Imaging TechnologiesMarket Set to Surge from $11.68 Billion in 2024 to $27.95 Billion by 2035 - GlobeNewswire
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - Asianet Newsable
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests - Yahoo Finance
Cardio Diagnostics Secures Medicare Coverage Path for AI-Powered Heart Disease Tests - StockTitan
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire
Cardio Diagnostics files to sell 1.23M shares of common stocks by selling shareholders - MSN
Cardio Diagnostics granted extension to regain Nasdaq compliance - Investing.com
Cardiovascular Devices Market Growth Driven by Innovations in Diagnosis and Treatment - openPR
Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2024Forecast, Trends - WhaTech
Heart Attack Diagnostic Market Size, Share, Trend Analysis, Segmentation And Forecast To 2033 - openPR
Heart Attack Diagnostics Market: What Represents The Key Growth - openPR
Cardio Diagnostics shareholders approve key proposals - Investing.com India
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Cardiovascular Monitoring & Diagnostic Devices Market 2024-2033Size, Trends & Competitive Analysis - openPR
CDIOCardio Diagnostics Holdings Inc Latest Stock News & Market Updates - StockTitan
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference - Yahoo Finance
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Analysts Provide Their Views On Cardio Diagnostics Holdings Inc (CDIO) - Stocks Register
In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Size, Trends And Overview 2024-2033 - openPR
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Direxion Daily NVDA Bull 2X Shares (NASDAQ:NVDU) Short Interest Down 38.4% in October - Defense World
Zanaga Iron Ore (LON:ZIOC) Stock Price Down 11.1% – Time to Sell? - Defense World
Cardiovascular Devices Market Size, Trends, Growth, - openPR
Is Cardio Diagnostics Holdings Inc (CDIO) worth investing in despite its overvalued state? - US Post News
Chief Medical Officer Philibert Robert acquire 34,075 shares of Cardio Diagnostics Holdings Inc [CDIO] - Knox Daily
Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Grows By 1,213.3% - Defense World
Investing in Cardio Diagnostics Holdings Inc (CDIO): What You Must Know - Knox Daily
Are Smart Investors Making the Right Decision? Cardio Diagnostics Holdings Inc (CDIO) - SETE News
Market Resilience: Cardio Diagnostics Holdings Inc (CDIO) Finishes Weak at 0.22, Down -2.53 - The Dwinnex
Can you still get a good price for Cardio Diagnostics Holdings Inc (CDIO) Shares at this point? - US Post News
Cardio Diagnostics Holdings Inc [CDIO] Shares Fall -6.52 % on Thursday - Knox Daily
CDIO’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Cardio Diagnostics nears Medicare reimbursement for CHD tests By Investing.com - Investing.com Canada
Cardio Diagnostics nears Medicare reimbursement for CHD tests - Investing.com
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cardio Diagnostics Holdings Inc Stock (CDIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dogan Meeshanthini | Chief Technology Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
197,310 |
| Dogan Meeshanthini | Chief Executive Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
1,683,867 |
| Burton Paul Frederick | Director |
Mar 31 '24 |
Option Exercise |
1.42 |
8,803 |
12,500 |
8,803 |
| Lau Stanley K. | Director |
Mar 31 '24 |
Option Exercise |
1.42 |
8,803 |
12,500 |
100,325 |
| Intrater James | Director |
Mar 31 '24 |
Option Exercise |
1.42 |
8,803 |
12,500 |
71,596 |
| Levy Oded | Director |
Mar 31 '24 |
Option Exercise |
1.42 |
8,803 |
12,500 |
71,596 |
1.31%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):